Compared with the control group, the knockdown of PRDX5, and the knockdown of Nrf2 and PRX5+Nrf2 could reduce the proliferation rate of NSCLC cells by 0.123, 0.273, and 0.569, respectively. Here, PRDX5 is linked to non-small cell lung carcinoma.